Metfendrazine

From Wikipedia, the free encyclopedia
Metfendrazine
Systematic (IUPAC) name
1-methyl-1-(1-methyl-2-phenyl-ethyl)hydrazine
Clinical data
Legal status Uncontrolled
Routes Oral
Identifiers
CAS number 3734-26-7
ATC code None
PubChem CID 19516
ChemSpider 18390
Chemical data
Formula C10H16N2 
Mol. mass 164.25 g/mol

Metfendrazine (HM-11, MO-482), also known as methphendrazine, is an irreversible and nonselective monoamine oxidase inhibitor (MAOI) of the hydrazine chemical class.[1][2] It was investigated as an antidepressant, but was never marketed.

See also

References

  1. Miquel, J., Mijan, C. D. (1962). "Metfendrazine, a new inhibitor of monoamine oxidase". Arch. Inst. Farmacol. Exp. (Madrid) 14: 47–59. 
  2. Kothari NJ, Saunders JC, Kline NS, Griffen JA (October 1960). "A comparison of perphenazine, proketazine, nialamide and MO-482 in chronic schizophrenics". The American Journal of Psychiatry 117: 358–60. PMID 13753478. 



This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.